Market Cap 29.77M
Revenue (ttm) 0.00
Net Income (ttm) -6.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,001,890
Avg Vol 6,800,928
Day's Range N/A - N/A
Shares Out 61.37M
Stochastic %K 21%
Beta 10.74
Analysts Strong Buy
Price Target N/A

Company Profile

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha,...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 931 6330
Address:
13576 Walnut Street, Suite A, Omaha, United States
Beanie_Mojo
Beanie_Mojo Sep. 9 at 8:57 PM
$KLTO ...... ...🤔....... hmm....
0 · Reply
DaSqueeza
DaSqueeza Sep. 9 at 6:59 PM
$KLTO will run AH! News imminent
0 · Reply
Boogerfloop19
Boogerfloop19 Sep. 9 at 6:48 PM
$KLTO .535 and just sits there
0 · Reply
Alessandro437
Alessandro437 Sep. 9 at 5:41 PM
$KLTO lol slapp that ask!! LFG
0 · Reply
Alessandro437
Alessandro437 Sep. 9 at 2:47 PM
0 · Reply
Tycoon_Trader
Tycoon_Trader Sep. 9 at 1:34 PM
$KLTO KLTO isn’t chasing hype—it’s building a legacy. With KLTO-101 targeting Alzheimer’s and KLTO-202 aimed at ALS, this company is advancing gene therapy with clinical rigor and commercialization foresight. As an investor, I look for more than potential—I look for execution. KLTO has it. Founder-led. Regulatory-proven. Mission-driven!!!
1 · Reply
Tycoon_Trader
Tycoon_Trader Sep. 9 at 1:30 PM
$KLTO My money and support are with Dr. Joseph Sinkule, Pharm.D., brings over 40 years of FDA navigation, product launches, and biotech leadership to the helm. His track record? ✅ 8 FDA-approved drugs and biologics ✅ 5 medical devices ✅ 8 in vitro diagnostics ✅ Strategic oversight across CROs, CDMOs, and global pharma partnerships! Just you wait and see!
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Sep. 9 at 10:42 AM
$IXHL $MVIS $KLTO $TELO are some of my bigger bets at the moment because they have valuable missions imo... but it’s crazy how many tickers today are running huge on presenting themselves as innovative businesses, and in reality their main asset is a pile of crypto tokens. For most of them, actual revenues are minimal. The valuation rides almost entirely on token holdings. It might work in a bull run, but it’s a fragile foundation for long-term business.
1 · Reply
Jesserhodes23
Jesserhodes23 Sep. 9 at 3:26 AM
$KLTO $1.50 for me ☹️
0 · Reply
zack_instock
zack_instock Sep. 9 at 2:27 AM
$KLTO $KLTO Did anyone buy at $3 b4?
1 · Reply
Latest News on KLTO
This Penny Stock Exploded 500% In June: What You Need To Know

Jun 30, 2025, 11:07 AM EDT - 2 months ago

This Penny Stock Exploded 500% In June: What You Need To Know


Beanie_Mojo
Beanie_Mojo Sep. 9 at 8:57 PM
$KLTO ...... ...🤔....... hmm....
0 · Reply
DaSqueeza
DaSqueeza Sep. 9 at 6:59 PM
$KLTO will run AH! News imminent
0 · Reply
Boogerfloop19
Boogerfloop19 Sep. 9 at 6:48 PM
$KLTO .535 and just sits there
0 · Reply
Alessandro437
Alessandro437 Sep. 9 at 5:41 PM
$KLTO lol slapp that ask!! LFG
0 · Reply
Alessandro437
Alessandro437 Sep. 9 at 2:47 PM
0 · Reply
Tycoon_Trader
Tycoon_Trader Sep. 9 at 1:34 PM
$KLTO KLTO isn’t chasing hype—it’s building a legacy. With KLTO-101 targeting Alzheimer’s and KLTO-202 aimed at ALS, this company is advancing gene therapy with clinical rigor and commercialization foresight. As an investor, I look for more than potential—I look for execution. KLTO has it. Founder-led. Regulatory-proven. Mission-driven!!!
1 · Reply
Tycoon_Trader
Tycoon_Trader Sep. 9 at 1:30 PM
$KLTO My money and support are with Dr. Joseph Sinkule, Pharm.D., brings over 40 years of FDA navigation, product launches, and biotech leadership to the helm. His track record? ✅ 8 FDA-approved drugs and biologics ✅ 5 medical devices ✅ 8 in vitro diagnostics ✅ Strategic oversight across CROs, CDMOs, and global pharma partnerships! Just you wait and see!
0 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Sep. 9 at 10:42 AM
$IXHL $MVIS $KLTO $TELO are some of my bigger bets at the moment because they have valuable missions imo... but it’s crazy how many tickers today are running huge on presenting themselves as innovative businesses, and in reality their main asset is a pile of crypto tokens. For most of them, actual revenues are minimal. The valuation rides almost entirely on token holdings. It might work in a bull run, but it’s a fragile foundation for long-term business.
1 · Reply
Jesserhodes23
Jesserhodes23 Sep. 9 at 3:26 AM
$KLTO $1.50 for me ☹️
0 · Reply
zack_instock
zack_instock Sep. 9 at 2:27 AM
$KLTO $KLTO Did anyone buy at $3 b4?
1 · Reply
Beanie_Mojo
Beanie_Mojo Sep. 8 at 9:41 PM
$KLTO pump dump pump dump pump dump
0 · Reply
knightseeker
knightseeker Sep. 8 at 7:11 PM
$KLTO Swing trade, looking for a move back over $1.00, oversold, waiting on more news
1 · Reply
rayankhader
rayankhader Sep. 8 at 2:46 PM
$KLTO break and hold above .55 $1 it will come fast
1 · Reply
LarryFeelTheHeaton
LarryFeelTheHeaton Sep. 8 at 2:45 PM
0 · Reply
AVCTQBNAPL
AVCTQBNAPL Sep. 8 at 2:42 PM
$KLTO https://finance.yahoo.com/news/klotho-neurosciences-ceo-attend-inaugural-120000513.html
0 · Reply
ezimon
ezimon Sep. 8 at 1:58 PM
$KLTO that is what normally happens when MMs and the company make an infinite amount of shares available to short ;-)
1 · Reply
zack_instock
zack_instock Sep. 8 at 1:30 PM
$KLTO drop again?
0 · Reply
rayankhader
rayankhader Sep. 8 at 12:27 PM
$KLTO I’m ready show me what you got
0 · Reply
whatascam
whatascam Sep. 8 at 11:44 AM
$KLTO Not a plan. Exciting times ahead.
2 · Reply
Jesserhodes23
Jesserhodes23 Sep. 8 at 3:26 AM
$KLTO what are we going to see this week?
0 · Reply
zack_instock
zack_instock Sep. 7 at 4:05 PM
$KLTO time to wake up..can u once go back to $3?
0 · Reply
Beanie_Mojo
Beanie_Mojo Sep. 7 at 2:41 PM
0 · Reply